Kejing Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kejing Wang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Jian-Lin Lou
Department of Head and Neck Surgery, Zhejiang Cancer Hospital, 38# Guangji Road, Hangzhous, 310022, China
1 shared publication - Liang Guo
Department of Head and Neck Surgery, Zhejiang Cancer Hospital, Hangzhou, 310022, People’s Republic of China
1 shared publication - Minghua Ge
Department of Head and Neck Surgery, Zhejiang Cancer Hospital, 38# Guangji Road, Hangzhous, 310022, China
1 shared publication - Shengye Wang
Department of Head and Neck Surgery, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China
1 shared publication - Su-Zhan Zhang
Department of Oncology, Second Affiliated Hospital, School of Medicine, Zhejiang University, 88# Jiefang Road, Hangzhou, 310009, China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 26 January 2015
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 13 (1) , 1-6
Metastasis of nasopharyngeal carcinoma to parotid lymph nodes: a retrospective study
Malignant parotid tumors are rare metastases originating from nasopharyngeal carcinoma (NPC). This study aimed to investigate the clinicopathological features and outcome of patients with metastasis of NPC to parotid lymph nodes after surgical therapy. We enrolled 14 NPC patients who had metastatic disease to parotid lymph nodes after IMRT. They received surgical treatment by total parotidectomy with neck dissection, superficial parotidectomy with neck dissection, partial parotidectomy with neck dissection, total parotidectomy, or superficial parotidectomy. Their age, gender, histopathology, clinical findings, and treatment outcome were analyzed. After radiotherapy, parotid metastasis represented as uncontrolled disease in three cases and as recurrent disease in 11 cases. All the 14 patients received salvaged surgery successfully. Pathologic findings showed grade 3 in most patients. The follow-up ranged from 11 to 120 months and the overall three- and five-year survival was 49.5% and 37.1%, respectively. Metastasis to parotid lymph nodes should be examined in NPC patients after IMRT. Resection of the inferior parotid lymph nodes is recommended for patients with cervical metastasis, and superficial or total parotidectomy and adjuvant therapy are recommended for intraparotid lymph node metastasis.
- 26 January 2015
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 13 (1) , 1-6
Top Cited PapersOpen AccessMetastasis of nasopharyngeal carcinoma to parotid lymph nodes: a retrospective study
Malignant parotid tumors are rare metastases originating from nasopharyngeal carcinoma (NPC). This study aimed to investigate the clinicopathological features and outcome of patients with metastasis of NPC to parotid lymph nodes after surgical therapy. We enrolled 14 NPC patients who had metastatic disease to parotid lymph nodes after IMRT. They received surgical treatment by total parotidectomy with neck dissection, superficial parotidectomy with neck dissection, partial parotidectomy with neck dissection, total parotidectomy, or superficial parotidectomy. Their age, gender, histopathology, clinical findings, and treatment outcome were analyzed. After radiotherapy, parotid metastasis represented as uncontrolled disease in three cases and as recurrent disease in 11 cases. All the 14 patients received salvaged surgery successfully. Pathologic findings showed grade 3 in most patients. The follow-up ranged from 11 to 120 months and the overall three- and five-year survival was 49.5% and 37.1%, respectively. Metastasis to parotid lymph nodes should be examined in NPC patients after IMRT. Resection of the inferior parotid lymph nodes is recommended for patients with cervical metastasis, and superficial or total parotidectomy and adjuvant therapy are recommended for intraparotid lymph node metastasis.